Loading...

Richard K Valicenti

TitleProf
InstitutionUniversity of California Davis
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Mayadev J, Klapheke A, Yashar C, Hsu IC, Kamrava M, Mundt AJ, Mell LK, Einck J, Benedict S, Valicenti R, Cress R. Underutilization of brachytherapy and disparities in survival for patients with cervical cancer in California. Gynecol Oncol. 2018 Apr 27. PMID: 29709291.
      View in: PubMed
    2. McGee HM, Daly ME, Azghadi S, Stewart SL, Oesterich L, Schlom J, Donahue R, Schoenfeld JD, Chen Q, Rao S, Fragoso RC, Valicenti R, Canter RJ, Maverakis EM, Murphy WJ, Kelly K, Monjazeb AM. Stereotactic Ablative Radiation Therapy Induces Systemic Differences in Peripheral Blood Immunophenotype Dependent on Irradiated Site. Int J Radiat Oncol Biol Phys. 2018 Apr 22. PMID: 29891204.
      View in: PubMed
    3. Mayadev J, Lim J, Durbin-Johnson B, Valicenti R, Alvarez E. Smoking Decreases Survival in Locally Advanced Cervical Cancer Treated With Radiation. Am J Clin Oncol. 2018 Mar; 41(3):295-301. PMID: 26808259.
      View in: PubMed
    4. Shi L, He Y, Yuan Z, Benedict S, Valicenti R, Qiu J, Rong Y. Radiomics for Response and Outcome Assessment for Non-Small Cell Lung Cancer. Technol Cancer Res Treat. 2018 Jan 01; 17:1533033818782788. PMID: 29940810.
      View in: PubMed
    5. Valicenti R, Pugh SL, Trabulsi EJ, Sartor O, Ko EC, Girvigian MR, Rosenthal SA, Shaves ME, Hoffman-Censits JH, Schallenkamp J, Sandler HM. First Report of NRG Oncology/Radiation Therapy Oncology Group 0622: A Phase 2 Trial of Samarium-153 Followed by Salvage Prostatic Fossa Irradiation in High-Risk Clinically Nonmetastatic Prostate Cancer After Radical Prostatectomy. Int J Radiat Oncol Biol Phys. 2018 Mar 01; 100(3):695-701. PMID: 29413282.
      View in: PubMed
    6. Mayadev J, Li CS, Lim J, Valicenti R, Alvarez EA. Alcohol Abuse Decreases Pelvic Control and Survival in Cervical Cancer: An Opportunity of Lifestyle Intervention for Outcome Improvement. Am J Clin Oncol. 2017 Oct; 40(5):451-457. PMID: 25784565.
      View in: PubMed
    7. Ko EC, Michaud AL, Valicenti R. Postoperative Radiation After Radical Prostatectomy. Semin Radiat Oncol. 2017 Jan; 27(1):50-66. PMID: 27986212.
      View in: PubMed
    8. Tait LM, Hoffman D, Benedict S, Valicenti R, Mayadev JS. The use of MRI deformable image registration for CT-based brachytherapy in locally advanced cervical cancer. Brachytherapy. 2016 May-Jun; 15(3):333-40. PMID: 26882845.
      View in: PubMed
    9. Sperduto PW, Shanley R, Luo X, Andrews D, Werner-Wasik M, Valicenti R, Bahary JP, Souhami L, Won M, Mehta M. Secondary analysis of RTOG 9508, a phase 3 randomized trial of whole-brain radiation therapy versus WBRT plus stereotactic radiosurgery in patients with 1-3 brain metastases; poststratified by the graded prognostic assessment (GPA). Int J Radiat Oncol Biol Phys. 2014 Nov 01; 90(3):526-31. PMID: 25304947.
      View in: PubMed
    10. Mayadev J, Fish K, Valicenti R, West D, Chen A, Martinez S, Phillips T. Utilization and impact of a postmastectomy radiation boost for invasive breast cancer. Pract Radiat Oncol. 2014 Nov-Dec; 4(6):e269-78. PMID: 25407878.
      View in: PubMed
    11. Mayadev J, Qi L, Lentz S, Benedict S, Courquin J, Dieterich S, Mathai M, Stern R, Valicenti R. Implant time and process efficiency for CT-guided high-dose-rate brachytherapy for cervical cancer. Brachytherapy. 2014 May-Jun; 13(3):233-9. PMID: 24559793.
      View in: PubMed
    12. Hoffman KE, Pugh SL, James JL, Scarantino C, Movsas B, Valicenti R, Fortin A, Pollock J, Kim H, Brachman DG, Berk LB, Bruner DW, Kachnic LA. The impact of concurrent granulocyte-macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trial. Qual Life Res. 2014 Aug; 23(6):1841-58. PMID: 24492945; PMCID: PMC4533105.
    13. Valicenti R, Thompson I, Albertsen P, Davis BJ, Goldenberg SL, Wolf JS, Sartor O, Klein E, Hahn C, Michalski J, Roach M, Faraday MM. Adjuvant and salvage radiation therapy after prostatectomy: American Society for Radiation Oncology/American Urological Association guidelines. Int J Radiat Oncol Biol Phys. 2013 Aug 01; 86(5):822-8. PMID: 23845839.
      View in: PubMed
    14. Rash DL, Lee YC, Kashefi A, Durbin-Johnson B, Mathai M, Valicenti R, Mayadev JS. Clinical response of pelvic and para-aortic lymphadenopathy to a radiation boost in the definitive management of locally advanced cervical cancer. Int J Radiat Oncol Biol Phys. 2013 Oct 01; 87(2):317-22. PMID: 23906933.
      View in: PubMed
    15. Lim J, Durbin-Johnson B, Valicenti R, Mathai M, Stern RL, Mayadev J. The impact of maximum rectal distention and tandem angle on rectal dose delivered in 3D planned gynecologic high dose-rate brachytherapy. Int J Gynecol Cancer. 2013 Jul; 23(6):1078-83. PMID: 23792603; PMCID: PMC3706279.
    16. Lim J, Durbin-Johnson B, Valicenti R, Mathai M, Stern RL, Mayadev J. The impact of body mass index on rectal dose in locally advanced cervical cancer treated with high-dose-rate brachytherapy. Brachytherapy. 2013 Nov-Dec; 12(6):550-4. PMID: 23706512.
      View in: PubMed
    17. Thompson IM, Valicenti R, Albertsen P, Davis BJ, Goldenberg SL, Hahn C, Klein E, Michalski J, Roach M, Sartor O, Wolf JS, Faraday MM. Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline. J Urol. 2013 Aug; 190(2):441-9. PMID: 23707439.
      View in: PubMed
    18. Kunos CA, Winter K, Dicker AP, Small W, Abdul-Karim FW, Dawson D, Jhingran A, Valicenti R, Weidhaas JB, Gaffney DK. Ribonucleotide reductase expression in cervical cancer: a radiation therapy oncology group translational science analysis. Int J Gynecol Cancer. 2013 May; 23(4):615-21. PMID: 23552804; PMCID: PMC3662019.
    19. Rash D, Hagar Y, Cui J, Hunt JP, Valicenti R, Mayadev J. Interfraction motion of the vaginal apex during postoperative intensity modulated radiation therapy: are we missing the target? Int J Gynecol Cancer. 2013 Feb; 23(2):385-92. PMID: 23287959.
      View in: PubMed
    20. Michalski J, Winter K, Roach M, Markoe A, Sandler HM, Ryu J, Parliament M, Purdy JA, Valicenti R, Cox JD. Clinical outcome of patients treated with 3D conformal radiation therapy (3D-CRT) for prostate cancer on RTOG 9406. Int J Radiat Oncol Biol Phys. 2012 Jul 01; 83(3):e363-70. PMID: 22633552; PMCID: PMC3361689.
    21. Greene DE, Mayadev JS, Valicenti R. Radiation treatment for patients with intermediate-risk prostate cancer. Ther Adv Urol. 2012 Jun; 4(3):113-24. PMID: 22654963; PMCID: PMC3361750.
    22. Perks JR, Stanic S, Stern RL, Henk B, Nelson MS, Harse RD, Mathai M, Purdy JA, Valicenti R, Siefkin AD, Chen AM. Failure mode and effect analysis for delivery of lung stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2012 Jul 15; 83(4):1324-9. PMID: 22197236.
      View in: PubMed
    23. Stanic S, Mathai M, Cui J, Purdy JA, Valicenti R. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2012 Apr 01; 82(5):1897-902. PMID: 21536391.
      View in: PubMed
    24. Valicenti R, Bae K, Michalski J, Sandler H, Shipley W, Lin A, Cox J. Does hormone therapy reduce disease recurrence in prostate cancer patients receiving dose-escalated radiation therapy? An analysis of Radiation Therapy Oncology Group 94-06. Int J Radiat Oncol Biol Phys. 2011 Apr 01; 79(5):1323-9. PMID: 21414514.
      View in: PubMed
    25. Gomella LG, Lin J, Hoffman-Censits J, Dugan P, Guiles F, Lallas CD, Singh J, McCue P, Showalter T, Valicenti R, Dicker A, Trabulsi EJ. Enhancing prostate cancer care through the multidisciplinary clinic approach: a 15-year experience. J Oncol Pract. 2010 Nov; 6(6):e5-e10. PMID: 21358951; PMCID: PMC2988679.
    26. Li B, Shi XB, Nori D, Chao CK, Chen AM, Valicenti R, White Rde V. Down-regulation of microRNA 106b is involved in p21-mediated cell cycle arrest in response to radiation in prostate cancer cells. Prostate. 2011 May; 71(6):567-74. PMID: 20878953.
      View in: PubMed
    27. Perks J, Turnbull H, Liu T, Purdy J, Valicenti R. Vector analysis of prostate patient setup with image-guided radiation therapy via kV cone beam computed tomography. Int J Radiat Oncol Biol Phys. 2011 Mar 01; 79(3):915-9. PMID: 20643510.
      View in: PubMed
    28. Valicenti R, Trabulsi E, Intenzo C, Lavarino J, Xu Y, Chervoneva I. A Phase I trial of samarium-153-lexidronam complex for treatment of clinically nonmetastatic high-risk prostate cancer: first report of a completed study. Int J Radiat Oncol Biol Phys. 2011 Mar 01; 79(3):732-7. PMID: 20399029.
      View in: PubMed
    29. Michalski JM, Bae K, Roach M, Markoe AM, Sandler HM, Ryu J, Parliament MB, Straube W, Valicenti R, Cox JD. Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study. Int J Radiat Oncol Biol Phys. 2010 Jan 01; 76(1):14-22. PMID: 19577865; PMCID: PMC2795116.
    30. Siglin J, Kubicek GJ, Leiby B, Valicenti R. Time of decline in sexual function after external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2010 Jan 01; 76(1):31-5. PMID: 19395191.
      View in: PubMed
    31. Michalski JM, Lawton C, El Naqa I, Ritter M, O'Meara E, Seider MJ, Lee WR, Rosenthal SA, Pisansky T, Catton C, Valicenti R, Zietman AL, Bosch WR, Sandler H, Buyyounouski MK, Ménard C. Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2010 Feb 01; 76(2):361-8. PMID: 19394158; PMCID: PMC2847420.
    32. Pe ML, Trabulsi EJ, Kedika R, Pequignot E, Dicker AP, Gomella LG, Valicenti R. Effect of percentage of positive prostate biopsy cores on biochemical outcome in low-risk PCa treated with brachytherapy or 3D-CRT. Urology. 2009 Jun; 73(6):1328-34. PMID: 19376564.
      View in: PubMed
    33. Linden RA, Weiner PR, Gomella LG, Dicker AP, Suh DB, Trabulsi EJ, Valicenti R. Technique of outpatient placement of intraprostatic fiducial markers before external beam radiotherapy. Urology. 2009 Apr; 73(4):881-6. PMID: 19193411.
      View in: PubMed
    34. Lawton CA, Michalski J, El-Naqa I, Kuban D, Lee WR, Rosenthal SA, Zietman A, Sandler H, Shipley W, Ritter M, Valicenti R, Catton C, Roach M, Pisansky TM, Seider M. Variation in the definition of clinical target volumes for pelvic nodal conformal radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2009 Jun 01; 74(2):377-82. PMID: 18947941; PMCID: PMC2905162.
    35. Trabulsi EJ, Valicenti R, Hanlon AL, Pisansky TM, Sandler HM, Kuban DA, Catton CN, Michalski JM, Zelefsky MJ, Kupelian PA, Lin DW, Anscher MS, Slawin KM, Roehrborn CG, Forman JD, Liauw SL, Kestin LL, DeWeese TL, Scardino PT, Stephenson AJ, Pollack A. A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer. Urology. 2008 Dec; 72(6):1298-302; discussion 1302-4. PMID: 18672274; PMCID: PMC4020432.
    36. Roach M, Bae K, Speight J, Wolkov HB, Rubin P, Lee RJ, Lawton C, Valicenti R, Grignon D, Pilepich MV. Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610. J Clin Oncol. 2008 Feb 01; 26(4):585-91. PMID: 18172188.
      View in: PubMed
    37. Showalter TN, Nawaz AO, Xiao Y, Galvin JM, Valicenti R. A cone beam CT-Based Study for Clinical Target Definition Using Pelvic Anatomy During Postprostatectomy Radiotherapy. Int J Radiat Oncol Biol Phys. 2008 Feb 01; 70(2):431-6. PMID: 17869021.
      View in: PubMed
    38. Lawton CA, DeSilvio M, Roach M, Uhl V, Kirsch R, Seider M, Rotman M, Jones C, Asbell S, Valicenti R, Hahn S, Thomas CR. An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions. Int J Radiat Oncol Biol Phys. 2007 Nov 01; 69(3):646-55. PMID: 17531401; PMCID: PMC2917177.
    39. Stephenson AJ, Scardino PT, Kattan MW, Pisansky TM, Slawin KM, Klein EA, Anscher MS, Michalski JM, Sandler HM, Lin DW, Forman JD, Zelefsky MJ, Kestin LL, Roehrborn CG, Catton CN, DeWeese TL, Liauw SL, Valicenti R, Kuban DA, Pollack A. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol. 2007 May 20; 25(15):2035-41. PMID: 17513807; PMCID: PMC2670394.
    40. Feng M, Hanlon AL, Pisansky TM, Kuban D, Catton CN, Michalski JM, Zelefsky MJ, Kupelian PA, Pollack A, Kestin LL, Valicenti R, DeWeese TL, Sandler HM. Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy. Int J Radiat Oncol Biol Phys. 2007 Aug 01; 68(5):1417-23. PMID: 17418972.
      View in: PubMed
    41. Pisansky TM, Pollack A, Sandler HM, Valicenti R. Advanced prostate cancer and postoperative radiotherapy. JAMA. 2007 Mar 07; 297(9):950-1; author reply 951. PMID: 17341706.
      View in: PubMed
    42. Roach M, DeSilvio M, Valicenti R, Grignon D, Asbell SO, Lawton C, Thomas CR, Shipley WU. Whole-pelvis, "mini-pelvis," or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial. Int J Radiat Oncol Biol Phys. 2006 Nov 01; 66(3):647-53. PMID: 17011443.
      View in: PubMed
    43. Valicenti R, DeSilvio M, Hanks GE, Porter A, Brereton H, Rosenthal SA, Shipley WU, Sandler HM. Posttreatment prostatic-specific antigen doubling time as a surrogate endpoint for prostate cancer-specific survival: an analysis of Radiation Therapy Oncology Group Protocol 92-02. Int J Radiat Oncol Biol Phys. 2006 Nov 15; 66(4):1064-71. PMID: 16979837.
      View in: PubMed
    44. Trabulsi EJ, Valicenti R. Dose escalation with proton-beam boost for low-risk prostate cancer. Nat Clin Pract Urol. 2006 May; 3(5):256-7. PMID: 16691237.
      View in: PubMed
    45. Wernicke AG, Valicenti R, Dieva K, Houser C, Pequignot E. Radiation dose delivered to the proximal penis as a predictor of the risk of erectile dysfunction after three-dimensional conformal radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2004 Dec 01; 60(5):1357-63. PMID: 15590165.
      View in: PubMed
    46. Febles C, Valicenti R. Combining external beam radiotherapy with prostate brachytherapy: issues and rationale. Urology. 2004 Nov; 64(5):855-61. PMID: 15533463.
      View in: PubMed
    47. Lee HM, Solan MJ, Lupinacci P, Gomella LG, Valicenti R. Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiotherapy. Urology. 2004 Jul; 64(1):84-9. PMID: 15245941.
      View in: PubMed
    48. Bednarz G, Michalski D, Anne PR, Valicenti R. Inverse treatment planning using volume-based objective functions. Phys Med Biol. 2004 Jun 21; 49(12):2503-14. PMID: 15272670.
      View in: PubMed
    49. Valicenti R, Chervoneva I, Gomella LG. Importance of margin extent as a predictor of outcome after adjuvant radiotherapy for Gleason score 7 pT3N0 prostate cancer. Int J Radiat Oncol Biol Phys. 2004 Mar 15; 58(4):1093-7. PMID: 15001249.
      View in: PubMed
    50. Michalski JM, Winter K, Purdy JA, Perez CA, Ryu JK, Parliament MB, Valicenti R, Roach M, Sandler HM, Markoe AM, Cox JD. Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV. Int J Radiat Oncol Biol Phys. 2004 Mar 01; 58(3):735-42. PMID: 14967428.
      View in: PubMed
    51. Gomella LG, Zeltser I, Valicenti R. Use of neoadjuvant and adjuvant therapy to prevent or delay recurrence of prostate cancer in patients undergoing surgical treatment for prostate cancer. Urology. 2003 Dec 29; 62 Suppl 1:46-54. PMID: 14747041.
      View in: PubMed
    52. Valicenti R, Winter K, Cox JD, Sandler HM, Bosch W, Vijayakumar S, Michalski J, Purdy J. RTOG 94-06: is the addition of neoadjuvant hormonal therapy to dose-escalated 3D conformal radiation therapy for prostate cancer associated with treatment toxicity? Int J Radiat Oncol Biol Phys. 2003 Nov 01; 57(3):614-20. PMID: 14529764.
      View in: PubMed
    53. Roach M, DeSilvio M, Lawton C, Uhl V, Machtay M, Seider MJ, Rotman M, Jones C, Asbell SO, Valicenti R, Han S, Thomas CR, Shipley WS. Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413. J Clin Oncol. 2003 May 15; 21(10):1904-11. PMID: 12743142.
      View in: PubMed
    54. Valicenti R, Gomella LG, Perez CA. Radiation therapy after radical prostatectomy: a review of the issues and options. Semin Radiat Oncol. 2003 Apr; 13(2):130-40. PMID: 12728442.
      View in: PubMed
    55. Valicenti R, Bissonette EA, Chen C, Theodorescu D. Longitudinal comparison of sexual function after 3-dimensional conformal radiation therapy or prostate brachytherapy. J Urol. 2002 Dec; 168(6):2499-504; discussion 2504. PMID: 12441949.
      View in: PubMed
    56. Valicenti R. The management of locally advanced prostate cancer. Prostate Cancer Prostatic Dis. 2002; 5 Suppl 2:S8-11. PMID: 12496990.
      View in: PubMed
    57. Chen CT, Valicenti R, Lu J, Derose T, Dicker AP, Strup SE, Mulholland SG, Hirsch IH, McGinnis DE, Gomella LG. Does hormonal therapy influence sexual function in men receiving 3D conformal radiation therapy for prostate cancer? Int J Radiat Oncol Biol Phys. 2001 Jul 01; 50(3):591-5. PMID: 11395224.
      View in: PubMed
    58. Valicenti R, Choi E, Chen C, Lu JD, Hirsch IH, Mulholland GS, Gomella LG. Sildenafil citrate effectively reverses sexual dysfunction induced by three-dimensional conformal radiation therapy. Urology. 2001 Apr; 57(4):769-73. PMID: 11306401.
      View in: PubMed
    59. Chen CT, Waterman FM, Valicenti R, Gomella LG, Strup SE, Dicker AP. Dosimetric analysis of urinary morbidity following prostate brachytherapy (125I vs. 103Pd) combined with external beam radiation therapy. Int J Cancer. 2001; 96 Suppl:83-8. PMID: 11992390.
      View in: PubMed
    60. Valicenti R, Gomella LG, El-Gabry EA, Myers R, Nathan F, Strup S, Dicker A, McGinnis DE, Cardi G, Baltish M, Simirgliano M, Vizzard A, Mulholland SG. The multidisciplinary clinic approach to prostate cancer counseling and treatment. Semin Urol Oncol. 2000 Aug; 18(3):188-91. PMID: 10975490.
      View in: PubMed
    61. Dicker AP, Figura AT, Waterman FM, Valicenti R, Strup SE, Gomella LG. Is there a role for antibiotic prophylaxis in transperineal interstitial permanent prostate brachytherapy? Tech Urol. 2000 Jun; 6(2):104-8. PMID: 10798809.
      View in: PubMed
    62. Valicenti R, Gomella LG. Durable efficacy of adjuvant radiation therapy for prostate cancer: will the benefit last? Semin Urol Oncol. 2000 May; 18(2):115-20. PMID: 10875451.
      View in: PubMed
    63. Reiff JE, Werner-Wasik M, Valicenti R, Huq MS. Changes in the size and location of kidneys from the supine to standing positions and the implications for block placement during total body irradiation. Int J Radiat Oncol Biol Phys. 1999 Sep 01; 45(2):447-9. PMID: 10487569.
      View in: PubMed
    64. Valicenti R, Gomella LG, Ismail M, Strup SE, Mulholland SG, Dicker AP, Petersen RO, Newschaffer CJ. The efficacy of early adjuvant radiation therapy for pT3N0 prostate cancer: a matched-pair analysis. Int J Radiat Oncol Biol Phys. 1999 Aug 01; 45(1):53-8. PMID: 10477006.
      View in: PubMed
    65. Valicenti R, Sweet JW, Hauck WW, Hudes RS, Lee T, Dicker AP, Waterman FM, Anne PR, Corn BW, Galvin JM. Variation of clinical target volume definition in three-dimensional conformal radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 1999 Jul 01; 44(4):931-5. PMID: 10386652.
      View in: PubMed
    66. Valicenti R, Gomella LG, Ismail M, Mulholland SG, Strup S, Petersen RO, Corn BW, Lu JD. Durable efficacy of early postoperative radiation therapy for high-risk pT3N0 prostate cancer: the importance of radiation dose. Urology. 1998 Dec; 52(6):1034-40. PMID: 9836551.
      View in: PubMed
    67. Valicenti R, Gomella LG, Ismail M, Mulholland SG, Petersen RO, Corn BW. Effect of higher radiation dose on biochemical control after radical prostatectomy for PT3N0 prostate cancer. Int J Radiat Oncol Biol Phys. 1998 Oct 01; 42(3):501-6. PMID: 9806507.
      View in: PubMed
    68. Valicenti R, Gomella LG, Ismail M, Mullholland SG, Petersen RO, Corn BW. Pathologic seminal vesicle invasion after radical prostatectomy for patients with prostate carcinoma: effect of early adjuvant radiation therapy on biochemical control. Cancer. 1998 May 15; 82(10):1909-14. PMID: 9587124.
      View in: PubMed
    69. Corn BW, Valicenti R, Mulholland SG, Hyslop T, Gomella L. Stage T3 prostate cancer: a nonrandomized comparison between definitive irradiation and induction hormonal manipulation plus prostatectomy. Urology. 1998 May; 51(5):782-7. PMID: 9610592.
      View in: PubMed
    70. Corn BW, Micaily B, Dunton CJ, Heller P, Valicenti R, Anderson L, Hernandez E. Concomitant irradiation and dose-escalating carboplatin for locally advanced carcinoma of the uterine cervix: an updated report. Am J Clin Oncol. 1998 Feb; 21(1):31-5. PMID: 9499253.
      View in: PubMed
    71. Valicenti R, Waterman FM, Corn BW, Curran WJ. A prospective, randomized study addressing the need for physical simulation following virtual simulation. Int J Radiat Oncol Biol Phys. 1997 Dec 01; 39(5):1131-5. PMID: 9392555.
      View in: PubMed
    72. Corn BW, Dunton CJ, Carlson JA, Xie Y, Valicenti R. National trends in the surgical staging of corpus cancer: a pattern-of-practice survey. Obstet Gynecol. 1997 Oct; 90(4 Pt 1):628-31. PMID: 9380328.
      View in: PubMed
    73. DiBiase SJ, Valicenti R, Schultz D, Xie Y, Gomella LG, Corn BW. Palliative irradiation for focally symptomatic metastatic renal cell carcinoma: support for dose escalation based on a biological model. J Urol. 1997 Sep; 158(3 Pt 1):746-9. PMID: 9258072.
      View in: PubMed
    74. Valicenti R, Waterman FM, Croce RJ, Corn B, Suntharalingam N, Curran WJ. Efficient CT simulation of the four-field technique for conformal radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys. 1997 Mar 01; 37(4):953-7. PMID: 9128974.
      View in: PubMed
    75. Michalski JM, Graham MV, Bosch WR, Wong J, Gerber RL, Cheng A, Tinger A, Valicenti R. Prospective clinical evaluation of an electronic portal imaging device. Int J Radiat Oncol Biol Phys. 1996 Mar 01; 34(4):943-51. PMID: 8598374.
      View in: PubMed
    76. Tinger A, Michalski JM, Bosch WR, Valicenti R, Low DA, Myerson RJ. An analysis of intratreatment and intertreatment displacements in pelvic radiotherapy using electronic portal imaging. Int J Radiat Oncol Biol Phys. 1996 Feb 01; 34(3):683-90. PMID: 8621293.
      View in: PubMed
    77. Kirov AS, Meigooni AS, Zhu Y, Valicenti R, Williamson JF. Quantitative verification of 192Ir PDR and HDR source structure by pin-hole autoradiography. Med Phys. 1995 Nov; 22(11 Pt 1):1753-7. PMID: 8587529.
      View in: PubMed
    78. Valicenti R, Kirov AS, Meigooni AS, Mishra V, Das RK, Williamson JF. Experimental validation of Monte Carlo dose calculations about a high-intensity Ir-192 source for pulsed dose-rate brachytherapy. Med Phys. 1995 Jun; 22(6):821-9. PMID: 7565373.
      View in: PubMed
    79. Valicenti R, Michalski JM, Bosch WR, Gerber R, Graham MV, Cheng A, Purdy JA, Perez CA. Is weekly port filming adequate for verifying patient position in modern radiation therapy? Int J Radiat Oncol Biol Phys. 1994 Sep 30; 30(2):431-8. PMID: 7928470.
      View in: PubMed
    80. Valicenti R, Wasserman TH, Monyak DJ, Kucik NA. Non-Hodgkin lymphoma: whole-abdomen irradiation as an adjuvant to chemotherapy. Radiology. 1994 Aug; 192(2):571-6. PMID: 8029434.
      View in: PubMed
    81. Micaily B, Miyamoto C, Valicenti R, Brady LW. Intracavitary brachytherapy for squamous cell carcinoma of the esophagus. Am J Clin Oncol. 1994 Apr; 17(2):170-4. PMID: 8141111.
      View in: PubMed
    82. Michalski JM, Wong JW, Bosch WR, Yan D, Cheng A, Gerber RL, Graham MV, Low D, Valicenti R, Piephoff JV. An evaluation of two methods of anatomical alignment of radiotherapy portal images. Int J Radiat Oncol Biol Phys. 1993 Dec 01; 27(5):1199-206. PMID: 8262848.
      View in: PubMed
    83. Valicenti R, Wasserman TH, Kucik NA. Analysis of prognostic factors in localized gastric lymphoma: the importance of bulk of disease. Int J Radiat Oncol Biol Phys. 1993 Oct 20; 27(3):591-8. PMID: 8226153.
      View in: PubMed